Return to search results
Maraviroc
Maraviroc is a generic prescription drug used to treat HIV infection by blocking the CCR5 co-receptor that the virus uses to enter immune cells. It comes as oral tablets in 150mg and 300mg strengths, manufactured by companies like Hetero Labs and Camber Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Maraviroc is a generic prescription drug used to treat HIV infection by blocking the CCR5 co-receptor that the virus uses to enter immune cells. It comes as oral tablets in 150mg and 300mg strengths, manufactured by companies like Hetero Labs and Camber Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Maraviroc",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Maraviroc — ANDA 217880 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217880"
}
]
|
| identifier | ANDA217880 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"health-care",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Maraviroc |
